Verdecchia P
General Hospital R. Silvestrini, Department of Cardiology, Ponte della Pietra, Perugia, Italy.
Blood Press Monit. 1999 Jun-Aug;4(3-4):175-9.
The measurement of blood pressure in the clinic triggers an altering reaction and a rise in blood pressure in the patient. Such a reaction is usually defined as a 'white-coat effect' or 'white-coat phenomenon', while the coexistence of persistently high office blood pressure with normal blood pressure outside the medical setting is referred to as 'white-coat' or 'office' hypertension. The white-coat effect can be estimated on a beat-to-beat basis using invasive (intra-arterial) or non-invasive methods, or, more commonly, by measuring the difference between office blood pressure and average daytime ambulatory blood pressure. The white-coat effect has little clinical importance because it is not associated with the target-organ damage and prognosis. We found that cardiovascular morbidities of healthy normotensive controls and subjects with white-coat hypertension did not differ. Results of a prospective study with intra-arterial blood pressure monitoring and preliminary prospective data from another group confirm our findings. A recent analysis of our database suggests that we should use a restrictive definition of white-coat hypertension (for example, average daytime blood pressure <130/80 mmHg) in order to identify the minority of subjects with low probabilities of developing a major cardiovascular event in the subsequent years. Also a recent document by the American Society of Hypertension suggests that one should use restrictive upper normal limits of ambulatory blood pressure (i.e., average daytime blood pressure <135 mmHg systolic and 85 mmHg diastolic). We have found that, over a follow-up period of 0.5-6.5 years, 37% of subjects with white-coat hypertension spontaneously evolve into ambulatory hypertension, with accompanying increase in left ventricular mass. The probability of developing ambulatory hypertension increased with the baseline values of ambulatory blood pressure, not of clinic blood pressure. A final answer on the clinical significance of white-coat hypertension will come from very large surveys of the natural history of this condition in the long term. Authors of these longitudinal studies should also compare the response to drug treatment of these subjects with that to life-style-modification measures.
在诊所测量血压会引发患者的反应变化及血压升高。这种反应通常被定义为“白大衣效应”或“白大衣现象”,而在医疗机构内持续高血压与医疗环境外正常血压并存的情况则被称为“白大衣”或“诊室”高血压。白大衣效应可通过有创(动脉内)或无创方法逐搏进行评估,或者更常见的是通过测量诊室血压与日间平均动态血压之间的差值来评估。白大衣效应在临床上意义不大,因为它与靶器官损害及预后无关。我们发现健康血压正常的对照者和白大衣高血压患者的心血管疾病发病率并无差异。一项采用动脉内血压监测的前瞻性研究结果以及另一组的初步前瞻性数据证实了我们的发现。最近对我们数据库的分析表明,我们应采用对白大衣高血压的严格定义(例如,日间平均血压<130/80 mmHg),以便识别出在随后几年发生重大心血管事件可能性较低的少数受试者。美国高血压学会最近的一份文件也表明,应采用动态血压的严格正常上限(即日间平均收缩压<135 mmHg,舒张压<85 mmHg)。我们发现,在0.5 - 6.5年的随访期内,37%的白大衣高血压患者会自发转变为动态高血压,同时左心室质量增加。发生动态高血压的概率随动态血压的基线值增加,而非诊室血压的基线值。关于白大衣高血压临床意义的最终答案将来自对此病症自然史的大规模长期调查。这些纵向研究的作者还应比较这些受试者对药物治疗与生活方式改变措施的反应。